WHO report highlights decline in global health spending in 2022

The 2024 Global Heath Expenditure Report by the World Health Organization (WHO) shows that the average per capita government spending on health in all country income groups fell in 2022 from 2021 after a surge in the early pandemic years.

Bicara, Zenas outline plans for $180M IPOs amid restored optimism for biotech debuts

Bicara Therapeutics and Zenas BioPharma are now a step closer to kicking open a mini-IPO window for drug developers this fall. The startups outlined plans

September 7, 2024

What to watch at ESMO: readouts from trials in lung, prostate, and other types of cancer

Europe’s major cancer research conference kicks off in Madrid on Friday, with headline — and potentially practice-changing — readouts from trials in lung, prostate, and

October 19, 2023

Eisai, Biogen make case for long-term use of Alzheimer’s drug Leqembi with new data

Patients with early Alzheimer’s disease treated with a medication developed by Eisai and Biogen for up to three years experienced less cognitive decline than what’s

July 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.